Doing their own due dilligence before making any investments is on potential investors to weigh their own risk reward senerio. I find the rewards of investing here to far outweigh the risk at this share price. But then again, that's me. I'm totally in now and don't lose any sleep over this investment. I like the fact that their strategy is to attack this disease upstream and to combine with another drug to repair some of the damage that has already been done.
“ANAVEX 2-73 was recognized by the independent publication Alzheimer's Weekly as "The number one most promising drug in Alzheimer's Disease" after their analysis of more than 100 trials that treat dementias and following the review of more than 10,000 articles.”
I understand the skepticism here. That goes with the territory when trading is on the pink sheets. But I think the skeptisim with this company is unwarranted. In my opinion, this company should be trading on a higher exchange. The science justifies a higher exchange but that's not how it works. We are so far ahead of the curve when it comes to finding a cure for AD and effective treatment for many other neurological diseases. We are looking for partnerships to provide the money needed to advance to more clinical trials. But until that time, if/when the warrants are exercised, I think that will provide the money to keep us going. Our CEO not only has a PhD in science but also an MBA. He was CFO of two other biotech companies, so I think he is the right guy to lead this company. This stock is a definite buy and hold; too risky to trade with all the possible announcements that I expect to be forthcoming in the immediate future. As always, do your own DD. There may be traders here making a few bucks, but in my opinion, they will miss the big payday. Just my opinion.